Skip to main content

Investor

By Mallory Hackett | 12:06 pm | September 25, 2020
Willow also reported a 140% increase in revenue growth year-over-year from 2018 to 2019, supported by a 120% growth in its mom user base YoY.   
By Mallory Hackett | 01:08 pm | September 24, 2020
With this financial support, Freeletics plans to develop new technologies, expand into new markets – especially in the U.S. – and create new business verticals.
By Dave Muoio | 12:47 pm | September 24, 2020
The Florida startup connects college and nursing students with seniors who need help with tasks or someone to talk to.
By Laura Lovett | 04:09 pm | September 23, 2020
At Rock Health's annual summit, a group of panelists discusses the importance of using inclusive language in digital health companies. 
By Mallory Hackett | 12:09 pm | September 22, 2020
Earlier this summer, the company announced plans to expand into new markets in 2021 and to add small-business plans in certain areas.
By Dave Muoio | 03:54 pm | September 21, 2020
Also: Hospital and health system software maker Olive closes $106 million; Ready's tech-enabled on-demand home care locks up $54 million.
By Laura Lovett | 04:28 pm | September 18, 2020
Some femtech companies struggle to get their ads approved on social media platforms due to prohibited-content rules and confusion of the rules. 
By Dave Muoio | 04:35 pm | September 17, 2020
Efficient distribution, dissipating stigma and an emphasis on decentralized trials are all working in favor of digital treatments, according to a panel of digital therapeutics executives and industry stakeholders.
By Mallory Hackett | 12:28 pm | September 17, 2020
Initially, Amwell planned to sell 35 million shares between $14 and $16 with up to 5.2 million additional shares for underwriters. 
By Dave Muoio | 04:35 pm | September 16, 2020
Activist short seller Citron Research called the Israeli digital X-ray company out on its limited R&D expenditure, suspicious distribution agreements and other factors. Nanox has described the report as incorrect and misleading.